Akorn Inc (AKRXQ)

OTC Markets
0.027
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.025 - 0.030
Trading near 52-week High

Akorn has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

1 / 2

AKRXQ Overview

Prev. Close
0.027
Day's Range
0.025-0.03
Revenue
120.31M
Open
0.027
52 wk Range
0.025-0.03
EPS
-2.79
Volume
0
Market Cap
3.6M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,340,011
P/E Ratio
-
Beta
0.514
1-Year Change
3.85%
Shares Outstanding
133,407,696
Next Earnings Date
-
What is your sentiment on Akorn?
or
Market is currently closed. Voting is open during market hours.

Akorn Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Akorn Inc Analysis

Akorn Inc Company Profile

Akorn Inc Company Profile

Employees
2227

Akorn Operating Company LLC, a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. The company was formerly known as Akorn, Inc. and changed its name to Akorn Operating Company LLC in October 2020. Akorn Operating Company LLC was founded in 1971 and is headquartered in Lake Forest, Illinois.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellSellStrong SellStrong Sell
SummaryStrong SellStrong SellSellStrong SellStrong Sell
  • my position expired. 10000 shares are gone. ****
    0
    • What's happening has changed its acronym????
      0
      • bankruptcy is done ?
        0
        • what do you think guys?
          0
          • I made 50% profit today and I am out
            0
            • Everything is screwed with this company
              0
              • Aí ai ai....
                0
                • What’s going on with company ? Free fall ....
                  0
                  • They almost done with BK and the stalking horse purchase agreement does not favor shareholders. Not even a little bit.
                    0
                • Is this fall normal?
                  0
                  • For a company almost done with bk? Yes, this is normal and it wont stop untill theres nothing left. Shareholders are going to get screwed
                    0
                • Anyone ? Is this the bottom ?
                  0